Historique
Rapport
Evaluation of drug prevention activities: theory and practice
Auteur(s) :
A. UHL ;
R. IVES ;
Groupe Pompidou
Article en page(s) :
64 p.
Domaine :
Plusieurs produits / Several products
Langue(s) :
Anglais
Thésaurus mots-clés
PREVENTION
;
EVALUATION
;
DEFINITION
;
FACTEUR DE PROTECTION
;
FACTEUR DE RISQUE
;
EFFICACITE
;
METHODE
;
CLASSIFICATION
Note générale :
P-PG/Prev(2010)6
Résumé :
This publication will explore the limitations for evaluation of drug prevention interventions and address the ways that evaluation can be made more effective. The Prevention Platform of the Pompidou Group (PG) of the Council of Europe has developed a framework of the publication in the context of the work undertaken in recent years in Europe to improve prevention interventions. The results of this work include "Handbook on prevention" by the PG and Jellinek Consultancy, "Prevention and evaluation resources kit" by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) as well as its database of good practices developed within the framework of the Exchange on Drug Demand Reduction Action (EDDRA), COST-A6 programme publications and the 2010 Prague Conference of the Pompidou Group "Prevention evaluation: from dogma to useful tool".
The purpose of this publication is to assist policymakers and their advisors in the decision-making process about the allocation of scarce resources for drug prevention. Evaluation is a key method for assessing the effectiveness of different approaches but it has its limitations. Policymakers often look for quick answers on "what works in prevention". There is also a certain tendency among practitioners and policymakers to think that "everything must be evaluated, if something is evaluated- it is proved to be good". Alfred Uhl (2000) created the word "evalopathy" to describe those tendencies. The topic of evaluation is a complex one; there are many different perspectives on evaluation. Defining what is meant by 'evaluation' in different contexts is crucial. It is important to point out where evaluation has become 'a dogma', and help policymakers and practitioners to ensure that evaluation is 'a useful tool'. (From the background)
The purpose of this publication is to assist policymakers and their advisors in the decision-making process about the allocation of scarce resources for drug prevention. Evaluation is a key method for assessing the effectiveness of different approaches but it has its limitations. Policymakers often look for quick answers on "what works in prevention". There is also a certain tendency among practitioners and policymakers to think that "everything must be evaluated, if something is evaluated- it is proved to be good". Alfred Uhl (2000) created the word "evalopathy" to describe those tendencies. The topic of evaluation is a complex one; there are many different perspectives on evaluation. Defining what is meant by 'evaluation' in different contexts is crucial. It is important to point out where evaluation has become 'a dogma', and help policymakers and practitioners to ensure that evaluation is 'a useful tool'. (From the background)
Affiliation :
Strasbourg, France
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |